Education
About Us
Working with TipRanks
Follow Us
Tonix Pharmaceuticals (DE:TPM)
BERLIN:TPM
TPM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.21 - $2.82
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
$68.17M
Enterprise Value-$10.32M
Total Cash (Recent Filing)$25.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.32
Next Earnings
Mar 17, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.15
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-3.41
Enterprise Value/Ebitda0.13
Forecast
1Y Price Target
$3.85Price Target Upside36.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Tonix Pharma News
PremiumCompany Announcements
Tonix Pharma Presents Promising Vaccine Data at Congress
PremiumCompany Announcements
Tonix Pharma’s TNX-102 SL Advances in FDA Process---
Options Prices
Currently, No data available
---
Ownership Overview
0.07%
Insiders
0.01%
Mutual Funds
0.04% Other Institutional Investors
99.88% Public Companies and Individual Investors
TPM FAQ
What was Tonix Pharmaceuticals’s price range in the past 12 months?
Tonix Pharmaceuticals lowest stock price was $2.21 and its highest was $2.82 in the past 12 months.
What is Tonix Pharmaceuticals’s market cap?
Tonix Pharmaceuticals’s market cap is $68.17M.
When is Tonix Pharmaceuticals’s upcoming earnings report date?
Tonix Pharmaceuticals’s upcoming earnings report date is Mar 17, 2025 which is 41 days ago.
How were Tonix Pharmaceuticals’s earnings last quarter?
Tonix Pharmaceuticals released its earnings results on Nov 12, 2024. The company reported -$22.281 earnings per share for the quarter, beating the consensus estimate of -$375.875 by $353.594.
Is Tonix Pharmaceuticals overvalued?
According to Wall Street analysts Tonix Pharmaceuticals’s price is currently Undervalued.
Does Tonix Pharmaceuticals pay dividends?
Tonix Pharmaceuticals does not currently pay dividends.
What is Tonix Pharmaceuticals’s EPS estimate?
Tonix Pharmaceuticals’s EPS estimate is -0.18.
How many shares outstanding does Tonix Pharmaceuticals have?
Currently, no data Available
What happened to Tonix Pharmaceuticals’s price movement after its last earnings report?
Tonix Pharmaceuticals reported an EPS of -$22.281 in its last earnings report, beating expectations of -$375.875. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Tonix Pharmaceuticals?
Currently, no hedge funds are holding shares in DE:TPM
---
Tonix Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.85 (36.58% Upside)
$3.85 (36.58% Upside)
Blogger Sentiment
Bullish
DE:TPM Sentiment 66%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.75%
12-Months-Change
Fundamentals
Return on Equity
-138.69%
Trailing 12-Months
Asset Growth
-31.80%
Trailing 12-Months
Company Description
Tonix Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.
---
TPM Stock 12 Month Forecast
Average Price Target
$3.85
▲(36.58% Upside)
Technical Analysis
Best Analysts Covering TPM
1 Year
1 Year Success Rate
0/18 ratings generated profit
1 Year Average Return
-81.45%
reiterated a buy rating 4 months ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -81.45% per trade.
---